Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an…
Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as…